药物对比
Dihydroergotamine vs Eptinezumab
比较 Dihydroergotamine（Migranal）与 Eptinezumab（Vyepti）用于偏头痛：急性治疗 vs 预防。了解机制、黑框警告、给药途径及适用性。
此页面暂无可用的对比维度。
临床背景
This comparison arises when migraine patients weigh acute abortive therapy against CGRP-based prevention.
结论
Neither is universally superior; DHE suits acute relief and eptinezumab suits prevention, pending medical evaluation.
全部药物对比